Beauty

Gymnema, which grows in the rainforests of India, has been used by Hindus for centuries to normalize blood sugar levels. Substances that make up gymnema, such as gymnemic acid, get on the tongue and block the sensation of sweetness. The application of potassium gymnemate (a substance isolated from this plant) to the tongue leads to a loss of perception of sweetness — sugar causes a feeling of sand in the mouth. The traditional use of Gymnema as a remedy for diabetes received scientific confirmation almost 70 years ago when the leaves of this plant were shown to reduce the sugar content in the urine of diabetics. Scientific substantiation of the effect of Gymnema on diabetic patients was not carried out until 1981, when it was again demonstrated that the intake of dried Gymnema leaves lowers blood sugar levels and increases serum insulin levels. Gymnema’s active ingredient, gymnemic acid, is believed to support insulin production. It is possible that in addition to supporting the body’s ability to control blood sugar levels, Gynemic Acid may help repair insulin-producing cells in the pancreas. It is also believed that gymnema is able to block the absorption of sugar in the gastrointestinal tract. Since diabetes usually does not appear until the pancreatic cells responsible for producing insulin have undergone serious damage, Gymnema extract is recommended not only for the treatment but also for the prevention of diabetes (especially in the elderly). It is interesting to note that Gymnema extract has no side effects and only has an effect on lowering blood sugar in diabetic patients. Gymnema extract has not been shown to lower blood sugar in healthy individuals. The fact that Gymnema extract reduced the need for conventional medications, increased serum insulin levels, and took several months to reach its optimal effect led scientists to conclude that B cells could be regenerated in type II diabetic patients. The condition of patients in the control group, observed during the study, not only did not improve during the experimental period, but actually worsened. An additional study of patients with type I diabetes showed the following results. Insulin requirements decreased along with blood sugar, glycated hemoglobin and glycated plasma protein levels. Serum lipid levels returned to normal. The most significant result was an increase in C-peptide levels in study participants. This is strong evidence of the resumption of insulin production, mainly due to the regeneration of B cells in the pancreas. Importantly, none of the study participants experienced any harmful side effects.